Bills · HR 6610
REPORTED· 119TH CONGRESS
House BillHR 6610Civil actions and liabilityJudicial review and appeals
Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act]
INTRO DEC 11· LAST ACTION JUL 22
READING
15MIN
COSPONSORS
44BIPARTISAN
READER REACTIONS0 TOTAL
NO VOTES YET · BE THE FIRST
- Introduced only
LEGISLATIVE PROGRESS
STEP 3 / 8Introduced
In Committee
Reported
Passed House
Passed Senate
Conference
To President
Became Law
WHAT THE BILL DOES
AI-writtenThis bill matters because it directly addresses concerns about the high cost of prescription drugs and the lack of transparency in how drug prices are set and managed by PBMs. For federal employees, it could mean real savings at the pharmacy counter, making essential medications more affordable. For local and independent pharmacies, it could create a more level playing field, ensuring they are fairly compensated and can compete effectively, potentially helping to keep more pharmacies open in communities.
If this bill becomes law, federal employees could experience more predictable drug costs and greater choice of pharmacies. Without it, the current system, which some argue allows PBMs to maintain high profits through opaque pricing and practices, would continue, potentially leading to higher out-of-pocket costs for federal workers and ongoing financial pressures for many pharmacies.
KEY PROVISIONS
5AI-extractedPROVISION 01
Requires Pharmacy Benefit Managers (PBMs) to reimburse in-network pharmacies for prescription drugs based on the national average drug acquisition cost (NADAC) plus a fixed fee and a professional dispensing fee.
This provision aims to ensure pharmacies receive fair and consistent payment for the medications they dispense, potentially stabilizing their financial health.
PROVISION 02
Mandates that PBMs apply manufacturer rebates at the point of sale, reducing a federal employee's co-insurance or co-payment based on the drug's net cost.
This directly lowers out-of-pocket prescription drug costs for federal employees at the time they purchase their medication.
PROVISION 03
Prohibits PBMs from directing federal employees to use specific pharmacies, including PBM-affiliated pharmacies, or from creating networks that exclude in-network pharmacies.
This provision promotes patient choice and fair competition among all in-network pharmacies.
PROVISION 04
Forbids PBMs from lowering pharmacy reimbursements or imposing fees on prescription drug claims after they have been processed.
This protects pharmacies from unexpected reductions in payment after a service has been rendered, providing greater financial predictability.
PROVISION 05
Establishes monetary penalties for PBMs that violate the new payment and operational requirements.
This provides a mechanism for enforcement, ensuring PBMs comply with the new regulations.
SPONSORSHIP
1 + 44
D· Massachusetts
YRS IN OFFICE
5
BILLS LED
12
COSPONSOR BREAKDOWNBIPARTISAN · 86%
DEM 19 REP 25 IND 0
ACTION TIMELINE
6 EVENTSJUL 22
Committee Consideration and Mark-up Session Held
JUL 22
Ordered to be Reported (Amended) by the Yeas and Nays: 40 - 2.
DEC 11
Introduced in House
DEC 11
Referred to the House Committee on Oversight and Government Reform.
BILL INFO
TypeHouse Bill
NumberHR 6610
Congress119th
StatusReported
IntroducedDec 11, 2025
Last actionJul 22, 2026
READER REACTIONS
OVERALL SENTIMENT
No reactions yet. Be the first to weigh in.
Discussion
Loading comments...
REPORTED· 119TH CONGRESS · OVERSIGHT AND GOVERNMENT REFORM COMMITTEE · INTRODUCED DEC 11, 2025
House BillHR 6610Civil actions and liabilityJudicial review and appeals
Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act]
INTRODUCED DEC 11, 2025· LAST ACTION JUL 22, 2026
PASSAGE CHANCES
—%
READING
15 min
COSPONSORS
44
COMPLEXITY
Moderate
